AUSTRALIS CAPITAL INC - AUSAF STOCK NEWS

Australis Capital Inc. (OTC: AUSAF) announced the launch of its first product in Nevada, Mr. Natural Full Spectrum Hash RSO, developed by Vietnam Veteran Bob "Natural" Luciano. The product aims to provide therapeutic relief for individuals suffering from PTSD, chronic illness, and pain, utilizing a proprietary extraction method to retain a full spectrum of cannabinoids. Mr. Natural has built a strong following among veterans. The product is now available at various dispensaries in Las Vegas and across Nevada.

Australis Capital Inc. (CSE: AUSA; OTC: AUSAF) announced a collaboration with the Black Institute Group to promote social equity initiatives, starting in New York State. The partnership aims to connect social equity applicants with AUDACIOUS and facilitate their participation in the cannabis industry. The Black Institute Group, led by civil rights leader Bertha Lewis, focuses on empowering Black communities and advocating for their rights in public policy. The collaboration will utilize B.I.G.'s expertise to guide AUDACIOUS in implementing its social equity programs effectively.

Australis Capital Inc. (AUSAF) has been granted provisional Cultivation and Manufacturing licenses in New Jersey, coinciding with the state's planned launch of adult-use marijuana sales on April 21, 2022. With approximately 9 million residents and a market opportunity estimated at nearly $2 billion, AUDACIOUS is positioned as an early mover with a limited number of licenses awarded. The company plans to establish an Achieve 24 facility, scalable to produce over 100,000 pounds of cannabis annually, and aims to secure a permanent location within 150 days to fully activate its licenses.

On April 12, 2022, Australis Capital Inc. (AUSAF) announced major developments in Thailand. The company is forging distribution agreements with prominent partners, including 7-Eleven and Loxley Public Company, to expand its CBD product sales. With a 25% stake in Golden Triangle Holdings (GTH), Australis will consolidate revenue, driving growth in the evolving Asian cannabis market. Their first clinic, Herbidus, serves 200 patients daily, with plans to open five more. A partnership with Khon Kaen University aids in cultivation and product development, enhancing operational capacity.

AUDACIOUS, a U.S. Multi-State Operator, has partnered with Golden Triangle Health to open Herbidus Medical Center in Bangkok, marking the first cannabis clinic in Southeast Asia. This clinic is legally authorized to prescribe medical cannabis in Thailand, which is experiencing a growing interest in the sector. The clinic has already attracted close to 800 patients post-launch, indicating strong demand. AUDACIOUS plans to leverage its expertise and partnership with Golden Triangle Health to expand in the Thai market, which has significant potential with a population of 70 million.

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) announced its fiscal Q3 2022 results, highlighting a remarkable 2,400% year-over-year revenue growth to $2.37 million. The company achieved 49% growth in gross margins compared to Q2, with gross profit rising to $1.84 million. Although operating expenses increased by 25.8% to $6.16 million, operating losses decreased by 14.7%. The company is expanding into new markets, including New York and New Jersey, and anticipates further revenue increases. A $10 million funding facility was secured to support growth initiatives.

Australis Capital Inc. (OTC: AUSAF) announced it will file its Q3 fiscal 2022 results on March 1, 2022, after market close. A conference call is scheduled for March 2, 2022, at 11:00 AM ET to discuss the results. Investors can access the call via a toll-free number or through a live webcast. The replay of the conference call will be available until March 9, 2022.

Australis Capital Inc. (CSE: AUSA, OTC: AUSAF) announced strategic expansions in cannabis markets both domestically and internationally. Notably, Thailand has approved the removal of cannabis from its controlled drugs list, enhancing growth prospects through their partner Golden Triangle Health. In the U.S., brands like LOOS and Provisions are gaining traction, with national partnerships underway. The company is pursuing license applications in Ohio, New Jersey, and New Mexico. ALPS continues to work on urban greenhouse projects and a major algae facility, contributing to AUDACIOUS's innovative growth strategy.

AUDACIOUS, led by CEO Terry Booth, has successfully acquired Lo͞oS, a cannabinoid-infused shot beverage company based in Santa Cruz, CA. This acquisition allows AUDACIOUS to significantly ramp up production and sales in California's burgeoning canna-beverage market. Lo͞oS products utilize unique nano-emulsion technology and are marketed as vegan, gluten-free, and low-calorie, infused with 100mg THC per shot. The company has issued 4,687,500 common shares as part of the transaction. This move aims to capitalize on increasing demand and expand into new markets throughout 2022.